The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CheMo4METPANC: Combination chemotherapy (gemcitabine and nab-paclitaxel), chemokine (C-X-C) motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in metastatic treatment-naïve pancreatic adenocarcinoma—Updated clinical and translational findings.
 
Gulam Manji
Stock and Other Ownership Interests - EnGeneIC
Honoraria - Celgene; Exelixis; Roche/Genentech
Consulting or Advisory Role - Cend Therapeutics; EnGeneIC; Exelixis; Ipsen; Pfizer; Revolution Medicines; Roche/Genentech
Research Funding - Arcus Biosciences; BiolineRx (Inst); Merck (Inst); Plexxikon (Inst); Regeneron (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Celgene; DAVA Oncology; Exelixis; Revolution Medicines; Roche/Genentech
 
Michael May
No Relationships to Disclose
 
Edridge D'Souza
No Relationships to Disclose
 
Ilenia Pellicciotta
No Relationships to Disclose
 
Sarah Sta Ana
No Relationships to Disclose
 
Naomi Sender
No Relationships to Disclose
 
Isabelle Ross
No Relationships to Disclose
 
Shikun Wang
No Relationships to Disclose
 
Susan Bates
Honoraria - Daiichi Sankyo/UCB Japan
Consulting or Advisory Role - Acrivon Therapeutics; Astellas Pharma (I); ElmediX; Pegascy
Research Funding - Ipsen (Inst); Pfizer (Inst); RenovoRx (Inst); Sun Biopharma (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending: METHODS FOR TREATING PANCREATIC CANCER WITH A COMBINATION OF ROMIDEPSIN AND DES-METHYL PATEAMINE A; Patent: Deacetylase Inhibitor Therapy (Inst); Patent: Depsipeptide for Therapy of Kidney Cancer (Inst)
 
Linda Wu
No Relationships to Disclose
 
Kenneth Olive
No Relationships to Disclose
 
Alexander Raufi
No Relationships to Disclose
 
Benjamin Izar
No Relationships to Disclose